BCTX

Briacell Therapeutics
BCTX

Overview Fund Activity

18 hedge funds and large institutions have $10.9M invested in Briacell Therapeutics in 2021 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 7 increasing their positions, 3 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
18
Holders Change
-1
Holders Change %
-5.26%
% of All Funds
0.28%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
7
Increased
7
Reduced
3
Closed
8
Calls
$11.9M
Puts
$4.62M
Net Calls
+$7.25M
Net Calls Change
+$7.25M

Top Buyers

1
Voloridge Investment Management
Voloridge Investment Management
Florida
+$385K
2
IA
Insight Advisors
Pennsylvania
+$140K
3
CWP
Concord Wealth Partners
Virginia
+$106K
4
TCWM
Total Clarity Wealth Management
Illinois
+$36.2K
5
AWM
Apollon Wealth Management
South Carolina
+$29.8K

Top Sellers

1
Two Sigma Investments
Two Sigma Investments
New York
-$503K
2
Geode Capital Management
Geode Capital Management
Massachusetts
-$326K
3
Jane Street
Jane Street
New York
-$285K
4
Belvedere Trading
Belvedere Trading
Illinois
-$107K
5
GG
Gofen & Glossberg
Illinois
-$81K
Name Holding Trade Value Shares
Change 		Shares
Change %
HI
26
Harbour Investments
Wisconsin
– -$1K -1 Closed
1
2